Stock Events

Stock Events

Quoin Pharmaceuticals

$4.26

0

+$0.06+1.43% Wednesday 02:06

Statistics

Day High

4.26

Day Low

4.2

52W High

6.17

52W Low

3.44

Volume

21

Avg. Volume

-

Mkt Cap

8.56M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Financials

-Profit Margin

Unprofitable

2020

2021

2022

2023

2024

2025

0Revenue

-15.81MNet Income

Analyst Ratings

$30.00Average Price Target

The highest estimate is 30.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.

Buy

100%

Hold

0%

Sell

0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QNRX.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Pfizer is a global pharmaceutical company that competes with Quoin Pharmaceuticals in the development and marketing of medications across various therapeutic areas.

Johnson & Johnson

Johnson & Johnson, through its pharmaceutical segment, competes in developing drugs that could directly compete with Quoin's product offerings.

Merck & Co., Inc. is involved in the discovery, development, manufacturing, and marketing of pharmaceuticals that can be in direct competition with Quoin Pharmaceuticals' products.

AbbVie operates in similar therapeutic areas as Quoin Pharmaceuticals, making it a competitor in the pharmaceutical industry.

Amgen is a biopharmaceutical company that competes with Quoin Pharmaceuticals in the development of innovative therapies.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose range of products competes with those of Quoin Pharmaceuticals.

Gilead Sciences

Gilead Sciences is involved in the research and development of pharmaceuticals that could compete with Quoin Pharmaceuticals in certain therapeutic areas.

Novartis is a global healthcare company that competes with Quoin Pharmaceuticals through its broad range of pharmaceutical products.

Roche Holding AG competes with Quoin Pharmaceuticals in the development and marketing of various pharmaceutical products.

Sanofi is a global pharmaceutical company that competes with Quoin Pharmaceuticals in several therapeutic areas, including rare diseases and immunology.

About

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Show more...

CEO

ISIN

US74907L4095

Listings

0 Comments

Share your thoughts

FAQ

What is Quoin Pharmaceuticals stock price today?▼

The current price of QNRX.BOATS is $4.26 USD — it has increased by +1.43% in the past 24 hours. Watch Quoin Pharmaceuticals stock price performance more closely on the chart.

What is Quoin Pharmaceuticals stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Quoin Pharmaceuticals stocks are traded under the ticker QNRX.BOATS.

What is Quoin Pharmaceuticals market cap?▼

Today Quoin Pharmaceuticals has the market capitalization of 8.56M

What is Quoin Pharmaceuticals revenue for the last year?▼

Quoin Pharmaceuticals revenue for the last year amounts to 0 USD.

What is Quoin Pharmaceuticals net income for the last year?▼

QNRX.BOATS net income for the last year is -15.81M USD.

In which sector is Quoin Pharmaceuticals located?▼

Quoin Pharmaceuticals operates in the Other sector.

When did Quoin Pharmaceuticals complete a stock split?▼

The last stock split for Quoin Pharmaceuticals was on April 09, 2025 with a ratio of 1:35.